Lupus nephritis: prolonged immunoadsorption (IAS) reduces proteinuria and stabilizes global disease activity | Zendy

Georg Stummvoll | Zendy; Sabine Schmaldienst | Zendy; Josef S Smolen | Zendy; Kurt Derfler | Zendy; Peter Biesenbach | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Lupus nephritis: prolonged immunoadsorption (IAS) reduces proteinuria and stabilizes global disease activity

Author(s) -

Georg Stummvoll,

Sabine Schmaldienst,

Josef S Smolen,

Kurt Derfler,

Peter Biesenbach

Publication year - 2011

Publication title -

nephrology dialysis transplantation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.654

H-Index - 168

eISSN - 1460-2385

pISSN - 0931-0509

DOI - 10.1093/ndt/gfr239

Subject(s) - medicine , proteinuria , immunoadsorption , lupus nephritis , gastroenterology , systemic lupus erythematosus , adverse effect , autoantibody , nephritis , anti dsdna antibodies , extracorporeal , disease , immunology , kidney , antibody

Systemic lupus erythematosus (SLE) is characterized by pathogenic autoantibodies, which can be removed by extracorporeal procedures. While previous studies have shown short-term efficacy of immunoadsorption (IAS) in SLE, no information on long-term benefit and safety is available.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research